Acquired by Ethicon Torax Medical was acquired by Ethicon, a Johnson & Johnson division, in early 2017, indicating a path to larger distribution channels and potential integration with a broader medical device portfolio.

Sphincter Disorder Focus Product portfolio centers on Magnetic Sphincter Augmentation (MSA) with LINX and FENIX systems, presenting cross-selling opportunities with surgeons and institutions treating GERD and fecal incontinence.

Growth Signals Historical Series E funding and acquisition by a major corporate parent suggest stability and potential for expanded sales force and marketing reach through Ethicon/JJ ecosystem.

Mid-market footprint Small to mid-sized company with 11-50 employees operating in medical device manufacturing, indicating a nimble sales approach but with access to large partners via Ethicon.

Revenue levers Current revenue range and past funding imply opportunities to position complementary devices, service contracts, or training programs to hospitals and clinics adopting LINX or FENIX systems.